Compare NSYS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSYS | TELA |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 41.3M |
| IPO Year | 1996 | 2019 |
| Metric | NSYS | TELA |
|---|---|---|
| Price | $14.50 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 20.9K | ★ 51.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.85 | 37.59 |
| EPS | ★ N/A | N/A |
| Revenue | $14,371,000.00 | ★ $80,275,000.00 |
| Revenue This Year | N/A | $10.23 |
| Revenue Next Year | N/A | $14.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.01 | ★ 15.84 |
| 52 Week Low | $6.50 | $0.50 |
| 52 Week High | $18.01 | $2.14 |
| Indicator | NSYS | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 41.34 |
| Support Level | $11.94 | $0.67 |
| Resistance Level | $15.11 | $0.75 |
| Average True Range (ATR) | 0.98 | 0.09 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 57.41 | 1.02 |
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.